Last Updated:
Name Designation Appointment Date Status
Ashwini Balu Nakade

Appointed as Director since February 2022

Director 10-Feb-2022 Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Trams Pharmaceuticals Private Limited.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.

Manisha Mahesh Marne

Appointed as Director since February 2022

Director 10-Feb-2022 Current
Sangeeta Deepak Lokhande

Appointed as Director since February 2022

Director 10-Feb-2022 Current
Reshma Vijay Lokhande

Appointed as Director since February 2022

Director 10-Feb-2022 Current

People Timeline

Explore the timeline of key personnel in Trams Pharmaceuticals Private Limited's leadership journey.

Loading...
Contact Details
  • Address Bld-B1 Gala1 Sec 20 Sch-2 Krishna Ngr Chinchwad, Pune Maharashtra, 411019, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 411019
  • Country India
  • Website -
Frequently Asked Questions
You can contact Trams Pharmaceuticals Private Limited through their registered address at Bld-B1 Gala1 Sec 20 Sch-2 Krishna Ngr Chinchwad, Pune Maharashtra, 411019, India, or via their website if available. Social media links are also provided where applicable.
The current directors of Trams Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • ASHWINI BALU NAKADE
  • MANISHA MAHESH MARNE
  • SANGEETA DEEPAK LOKHANDE
  • RESHMA VIJAY LOKHANDE
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available